Clinical trial
Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients…
NCT00434317 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00434317 |
|---|---|
| Title | Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases |
| Official title | A Multicenter, Open-label Study to Determine the Effect of iv. Zoledronic Acid on Pain and Quality of Life in Patients With Bone Metastases With or Without Skeletal Related Events (SRE) Resulting From Breast Cancer and Prostate Cancer |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 80 |
| Start date | Aug 1, 2005 |
| Primary completion | Apr 1, 2008 |
| First posted | Feb 13, 2007 |
| Last update posted | Feb 23, 2017 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: